Erica L Clinkenbeard Selected Research

Hypophosphatemia

4/2016	Excessive Osteocytic Fgf23 Secretion Contributes to Pyrophosphate Accumulation and Mineralization Defect in Hyp Mice.
1/2016	Conditional Deletion of Murine Fgf23: Interruption of the Normal Skeletal Responses to Phosphate Challenge and Rescue of Genetic Hypophosphatemia.
6/2013	Osteocyte regulation of phosphate homeostasis and bone mineralization underlies the pathophysiology of the heritable disorders of rickets and osteomalacia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Erica L Clinkenbeard Research Topics

Disease

7	Hypoxia (Hypoxemia) 01/2023 - 02/2014
5	Chronic Renal Insufficiency 01/2023 - 01/2019
5	Hyperphosphatemia 01/2021 - 12/2014
3	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 01/2022 - 06/2017
3	Iron Deficiencies 09/2021 - 02/2014
3	Anemia 01/2021 - 02/2014
3	Hypophosphatemia 04/2016 - 06/2013
3	Osteomalacia 04/2016 - 12/2012
2	Vascular Calcification 04/2017 - 12/2014
2	Rickets (Rachitis) 04/2016 - 06/2013
2	Familial Hypophosphatemic Rickets (X-Linked Hypophosphatemia) 04/2016 - 06/2013
2	Autosomal Dominant Hypophosphatemic Rickets 02/2014 - 06/2013
1	Chronic Disease (Chronic Diseases) 01/2023
1	Azotemia 01/2022
1	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 01/2022
1	Fibrosis (Cirrhosis) 01/2020
1	Atherosclerosis 01/2019
1	Body Weight (Weight, Body) 01/2019
1	Cardiomegaly (Heart Hypertrophy) 01/2019
1	Weight Gain 01/2019
1	Endocrine System Diseases (Endocrine Diseases) 01/2019
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019
1	Infertility (Sterility) 01/2016
1	Bone Diseases (Bone Disease) 01/2016
1	Calcinosis 12/2014
1	Familial Hyperphosphatemic Tumoral Calcinosis 10/2014
1	Hypophosphatemic Rickets 06/2013

Drug/Important Bio-Agent (IBA)

9	Phosphates (Orthophosphate)IBA 01/2023 - 06/2013
7	IronIBA 01/2023 - 02/2014
6	MineralsIBA 01/2022 - 01/2016
6	Fibroblast Growth Factor-23IBA 01/2022 - 02/2014
5	Hormones (Hormone)IBA 01/2023 - 10/2014
4	Proteins (Proteins, Gene)FDA Link 09/2021 - 06/2013
3	Prolyl-Hydroxylase InhibitorsIBA 01/2023 - 01/2020
3	Erythropoietin FDA Link 01/2021 - 03/2019
3	Messenger RNA (mRNA)IBA 01/2020 - 12/2012
2	Oxygen (Dioxygen)IBA 01/2023 - 02/2014
2	Transcription Factors (Transcription Factor)IBA 01/2023 - 06/2017
2	ferric citrateIBA 01/2022 - 01/2022
2	Phosphorus (Red Phosphorus)IBA 01/2022 - 01/2016
2	NitrogenIBA 01/2021 - 01/2019
2	Urea (Carbamide)FDA LinkGeneric 01/2021 - 01/2019
1	EnzymesIBA 01/2023
1	Saccharated Ferric Oxide (Venofer)FDA Link 01/2022
1	Parathyroid Hormone (Parathormone)IBA 01/2022
1	Transferrin Receptors (Transferrin Receptor)IBA 09/2021
1	Chelating AgentsIBA 01/2021
1	Transferrin (beta 2 Transferrin)IBA 01/2021
1	molidustatIBA 01/2021
1	Vitamin D3 24-HydroxylaseIBA 01/2020
1	roxadustatIBA 01/2020
1	HematinicsIBA 01/2020
1	25-Hydroxyvitamin D3 1-alpha-Hydroxylase (25 Hydroxyvitamin D3 1 alpha Hydroxylase)IBA 01/2020
1	LipidsIBA 01/2019
1	Adenine FDA LinkGeneric 01/2019
1	EndopeptidasesIBA 04/2016
1	Vitamin D FDA LinkGeneric 04/2016
1	SubtilisinIBA 06/2013
1	CateninsIBA 06/2013

Therapy/Procedure

1	Therapeutics 01/2022
1	Surgical Amputation (Amputations) 12/2014